Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print March 20, 2006, 10.1148/radiol.2392042110
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2392042110v1
239/2/415    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fortin-Ripoche, J.-P.
Right arrow Articles by Clément, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fortin-Ripoche, J.-P.
Right arrow Articles by Clément, O.
(Radiology 2006;239:415-424.)
© RSNA, 2006

Experimental Studies

Magnetic Targeting of Magnetoliposomes to Solid Tumors with MR Imaging Monitoring in Mice: Feasibility1

Jean-Paul Fortin-Ripoche, MS, Marie Sophie Martina, MS, Florence Gazeau, PhD, Christine Ménager, PhD, Claire Wilhelm, PhD, Jean-Claude Bacri, PhD, Sylviane Lesieur, PhD and Olivier Clément, MD, PhD

1 From the Laboratoire Matière et Systèmes Complexes, Groupe Physique du Vivant, Université Paris 7, MSC, 140 rue de Lourmel, 75015 Paris, France (J.P.F., F.G., C.W., J.C.B.); Laboratoire de Recherche en Imagerie, Faculté de Médecine Necker, Paris, France (J.P.F., O.C.); Equipe Physico-Chimie des Systèmes Polyphasés, Faculté de Pharmacie, Chatenay-Malabry, France (M.S.M., S.L.); and Laboratoire des Liquides Ioniques et Interfaces Chargées, Université Paris 6, Paris, France (C.M.). Received December 13, 2004; revision requested February 7, 2005; revision received May 2; accepted June 3; final version accepted July 20. Supported by the French Ministry of Education and Research, Centre National de la Recherche Scientifique (ACI Nanoscience et Nanotechnologie NR145), and Institut National de la Santé et de la Recherche Médicale (Programme Interdisciplinaire Imagerie du Petit Animal). Address correspondence to J.P.F. (e-mail: fortin{at}ccr.jussieu.fr).

Purpose: To establish the feasibility of magnetoliposome tumor targeting with an extracorporeal magnet.

Materials and Methods: Animal experiments were performed in compliance with Institut National de la Santé Et de la Recherche Médicale animal protection guidelines and were approved by local government authorities. Magnetophoresis was used to measure the velocity of magnetoliposomes constituted of polyethylene glycol–lipids and anionic maghemite nanocrystals in a calibrated magnetic field in vitro. For in vivo studies, 38 male Swiss nude mice bearing a PC3 human prostate carcinoma tumor in each flank received an intravenous injection of magnetoliposomes (n = 27), saline (n = 9), or nonencapsulated superparamagnetic particles (n = 2) after a small magnet with a magnetic field of 0.3 T and a field gradient of 11 T/m was fixed to the skin above one tumor. The animals were examined at magnetic resonance (MR) imaging with eight different sequences, iron doses (13 mice), and magnet-application durations (12 mice). Their excised tumors were then stained with Perls Prussian blue and hematoxylin-eosin and were examined histologically. With use of the paired Student t test, signal intensity, tumor surface enhancement, and number of stained cells were compared between the control and magnet-exposed tumors to determine significant differences (P ≤ .01).

Results: The mean magnetoliposome velocity ranged from 10 to 40 µm/sec when the magnetic field equaled 0.13 T and the field gradient equaled 25 T/m. At T1-weighted three-dimensional spoiled gradient-echo MR imaging in vivo, the tumor exposed to the magnet showed strong negative enhancement, –52%, compared with the –7% enhancement of the other tumor. Maximal enhancement occurred after 3 hours of magnet application. After 24 hours of magnet application, intracapillary iron particle accumulation was observed in the targeted tumors only.

Conclusion: Magnetic targeting of sterically stabilized magnetoliposomes after they are intravenously injected is feasible in vivo.




This article has been cited by other articles:


Home page
 RadiologyHome page
C. Riviere, M.-S. Martina, Y. Tomita, C. Wilhelm, A. Tran Dinh, C. Menager, E. Pinard, S. Lesieur, F. Gazeau, and J. Seylaz
Magnetic Targeting of Nanometric Magnetic Fluid loaded Liposomes to Specific Brain Intravascular Areas: A Dynamic Imaging Study in Mice
Radiology, August 1, 2007; 244(2): 439 - 448.
[Abstract] [Full Text] [PDF]